NCT06412471SSGJ-707tislelizumab
…TPS) ≥1. We report safety and efficacy from the phase 2 study ( NCT06412471) of SSGJ-707 combined with platinum-based chemotherapy in first…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT06412471 ×
NCT06412471
This institution is selected. Its supporting articles are shown below.